The GI Board Exams have a pass rate around 94%, but you are definitely going to need to prepare . For this type of exam, it’s best to focus on the core material – make sure you know the basics, and drill questions on a few areas where you may be lacking. Below are a couple of sample Gastroenterology Board Questions. We recommend using our content suggestion tool to identify strengths and weaknesses.
Sample Gastroenterology Board Questions
Question 1. Small Bowel QID 16191
A 20 year old male college student is diagnosed with celiac disease based on serologic and histologic evaluation. He is started on a gluten-free diet that he has taken great pains to follow despite his busy schedule. He notes that he only buys grains and cereals, including oatmeal, which are labeled as gluten free even when dining in the school cafeteria. However, his symptoms continue to persist. Which of the following items in his diet is least likely to be contaminating his gluten-free diet?
A. Béchamel sauce
B. Buckwheat pancakes
C. Strawberry milk
D. Herbal tea
Answer: B. Buckwheat pancakes.
Buckwheat pancakes are made from buckwheat, which does not contain gluten and does not exacerbate celiac disease. Béchamel sauce, as well as other sauces and marinades, may contain thickeners that contribute gluten to the diet. This is not always obvious, especially given that he likely eats part of the time in the college cafeteria. Strawberry milk, as well as other flavored milks, may contain thickeners, and/or other additives that could contribute gluten to his diet. Some herbal teas may also contain gluten, depending on their composition. Thus, the current American College of Gastroenterology guidelines for the management of celiac disease, recommends that all patients with non-responsive celiac disease meet with a dietician to ensure that their diets are devoid of gluten given not all products are necessarily labeled for this purpose. Key Point: All patients with celiac disease need to meet with a dietician in order to be adequately educated regarding dietary sources of gluten.
Reference: Bibliography: 1. Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA, American College of G. ACG clinical guidelines: diagnosis and management of celiac disease. The American journal of gastroenterology. 2013 May;108(5):656-76; quiz 77. PubMed PMID: 23609613. Pubmed Central PMCID: 3706994.
Question 2. Stomach QID 16011
Which of the following statements regarding the use of endoclips in the management of GI bleeding is true?
A. Endoclip alone is superior to injection therapy in the management of Dieulefoy lesions as well as Mallory-Weiss tears
B. Endoclip is the preferred mode of treatment for diverticular bleeds, as it has been proven to a lower incidence of perforation than thermal coagulation therapy
C. Endoclip therapy has been shown to be effective not only in achieving hemostasis in both immediate and delayed post-polypectomy bleeding but also in the prevention of post-polypectomy bleeding in patients at high risk for this complication
D. Endoclip therapy for gastrointestinal bleeding secondary to peptic ulcer disease, when compared to thermal coagulation therapy, has similar rates of hemostasis but a lower all-cause mortality rate
E. For hemostasis, endoclip therapy is superior to thermal coagulation therapy in the management of gastrointestinal bleeding secondary to peptic ulcer disease
Answer: C. Endoclip therapy has been shown to be effective not only in achieving hemostasis in both immediate and delayed post-polypectomy bleeding but also in the prevention of post-polypectomy bleeding in patients at high risk for this complication.
Multiple studies have shown that in immediate post-polypectomy bleeding, definitive hemostasis can be achieved using endoclip therapy in nearly100% of patients. In delayed post-polypectomy bleeding, hemostasis is achieved in over 90% of patients. Additionally, it patients at high risk for post-polypectomy bleeding (either due to location or size of polyp removed or due to need for anti-coagulation / anti-platelet therapy), prophylactic clip placement preventing bleeding in all patients(1). Endoclip therapy is perceived to have a higher risk of perforation than thermal coagulation therapy for diverticular bleeds(1). In gastrointestinal bleeds related to peptic ulcer disease, endoclip therapy has similar hemostasis and comparable all-cause mortality rates when compared to thermal coagulation therapy. Thus, D and E are both incorrect(1). Key Point: Endoclip therapy is effective not only in the management of both early and delayed post-polypectomy bleeding but also in preventing bleeds in high-risk polypectomies.
Reference: Bibliography: 1. Anastassiades CP, Baron TH, Wong Kee Song LM. Endoscopic clipping for the management of gastrointestinal bleeding. Nature clinical practice Gastroenterology & hepatology. 2008 Oct;5(10):559-68. PubMed PMID: 18711412. Epub 2008/08/20.